efalizumab < effect < effecting

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 317.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000002 (2005)	Radouil Tzekov [États-Unis]	Ocular Toxicity Due to Chloroquine and Hydroxychloroquine:Electrophysiological and Visual Function Correlates
000004 (1990)	Susan Tett ; David Cutler ; Richard Day	Antimalarials in rheumatic diseases
000010 (2006)	Vicente Giner Galva [Espagne] ; María Rosa Oltra [Espagne] ; Diego Rueda [Espagne] ; María José Esteban [Espagne] ; Josep Red N [Espagne]	Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease
000012 (1998)	Jan Bondeson [Suède] ; Roger Sundler [Suède]	Antimalarial Drugs Inhibit Phospholipase A2 Activation and Induction of Interleukin lβ and Tumor Necrosis Factor α in Macrophages: Implications for Their Mode of Action in Rheumatoid Arthritis
000019 (1988)	J. A. Roberts [Royaume-Uni] ; A. Gunneberg [Royaume-Uni] ; J. A. Elliott [Royaume-Uni] ; N. C. Thomson [Royaume-Uni]	Hydroxychloroquine in steroid dependent asthma
000030 (2006)	G. Ruiz-Irastorza [Niger] ; M-V Egurbide [Espagne] ; J-I Pijoan [Espagne] ; M. Garmendia [Espagne] ; I. Villar [Espagne] ; A. Martinez-Berriotxoa [Espagne] ; J-G Erdozain [Espagne] ; C. Aguirre [Espagne]	Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
000031 (1988)	Hanne Hjorth T Nnesen [Norvège] ; Anne-Lise Grislingaas [Norvège] ; Soo On Woo [Singapour] ; Jan Karlsen [Norvège]	Photochemical stability of antimalarial. I. Hydroxychloroquine
000032 (2015)	Sarah Braun [Allemagne] ; Marion Ferner [Allemagne] ; Kai Kronfeld [Allemagne] ; Matthias Griese [Allemagne]	Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases
000036 (1995)	Yimin Wei [États-Unis] ; Gloria A. Nygard [États-Unis] ; Shari L. Ellertson [États-Unis] ; Shoukry K. W. Khalil [États-Unis]	Stereoselective disposition of hydroxychloroquine and its metabolites in rats
000038 (2008)	R. Fischer-Betz [Allemagne] ; M. Schneider [Allemagne]	Antimalariamittel
000046 (2001)	Johan R. Boelaert [Belgique] ; Jacques Piette [Belgique] ; Kirk Sperber [États-Unis]	The potential place of chloroquine in the treatment of HIV-1-infected patients
000054 (1999)	Rachida Legssyer [Belgique] ; Roberta J. Ward [Belgique] ; Robert R. Crichton [Belgique] ; Johan R. Boelaert [Belgique]	Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages
000074 (2006)	A. Parke [États-Unis]	Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases
000077 (1994)	Michelle Petri [États-Unis] ; Christiana Lakatta [États-Unis] ; Laurence Magder [États-Unis] ; Daniel Goldman [États-Unis]	Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis
000080 (2011)	Jean M. Mulcahy Levy [États-Unis] ; Andrew Thorburn [États-Unis]	Modulation of pediatric brain tumor autophagy and chemosensitivity
000083 (2000)	Bettina Wedi [Allemagne] ; Vera Novacovic [Allemagne] ; Michael Koerner [Allemagne] ; Alexander Kapp [Allemagne]	Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression—Inhibitory effects of anti-inflammatory drugs
000099 (1996)	S. Ten Wolde [Pays-Bas] ; F. C. Breedveld [Pays-Bas] ; B. A. C. Dijkmans [Pays-Bas] ; J. Hermans [Pays-Bas] ; J. P. Vandenbroucke [Pays-Bas] ; M. A. F. J. Van De Laar [Pays-Bas] ; H. M. Markusse [Pays-Bas] ; M. Janssen [Pays-Bas] ; H. R. Van Den Brink [Pays-Bas]	Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
000100 (2000)	A. Barbato [Italie] ; C. Panizzolo [Italie]	Recent Advances
000107 (1988)	Michael J. Manyak [États-Unis] ; Paul D. Smith [États-Unis] ; Frank S. Harrington [États-Unis] ; Seth M. Steinberg [États-Unis] ; Eli Glatstein [États-Unis] ; Angelo Russo [États-Unis]	PROTECTION AGAINST DIHEMATOPORPHYRIN ETHER PHOTOSENSITIVITY
000110 (1978)	D. T. Okpako [Nigeria]	Interactions of aminoquinolines and mepacrine with prostaglandins E2 in tissues of rats and guinea-pigs
000112 (2001)	Robert Jarzyna [Pologne] ; Anna Kiersztan [Pologne] ; Olesia Lisowa [Pologne] ; Jadwiga Bryła [Pologne]	The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "effect" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "effect" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    effect
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021